As DaVita has underperformed relative to the Dow over the past year, Wall Street analysts maintain a cautious outlook on the ...

DaVita, Inc. DVA has witnessed strong momentum year to date. Its shares have risen 40.1% compared with the industry’s growth of 11.5%. The S&P 500 composite has gained 27.7% in the same period. DaVita ...

If you are wondering whether DaVita at around $118 a share is a bargain or a value trap, you are not alone. This breakdown is ...

Shares of DaVita DVA have risen 115.5% in the past year, outperforming the Zacks Medical - Outpatient and Home Healthcare industry’s growth of 37.8% and the broader Zacks Medical sector’s return of 12 ...

Shares of DaVita (NYSE: DVA) climbed 8.6% on Wednesday after the dialysis services company announced strong fourth-quarter 2023 results. DaVita's quarterly revenue grew 7.8% year over year to $3.15 ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

We recently compiled a list titled Buffett Stock Portfolio: Top 10 Stock Picks for 2024. In this article, we will look at where DaVita Inc. (NYSE:DVA) ranks among the top 10 stocks in Buffet’s ...

DaVita (DVA) is rated a speculative 'Buy,' reflecting undervaluation despite recent earnings volatility. DVA's moat stems ...

DaVita disclosed the incident on Monday in a regulatory filing. The company said that on the previous Saturday, April 12, it was subject to a ransomware attack. When the attack was discovered by ...

DaVita is a stock that has been in Warren Buffett's portfolio for many years. Now the company is under short-term pressure from higher patient costs, labor issues, higher interest expenses, and lower ...

DaVita beat revenue and earnings estimates for its fourth quarter. The company has proven resilient in the wake of the COVID-19 pandemic. DaVita's quarterly revenue grew 7.8% year over year to $3.15 ...